USPTO serial 87149151
STEIIIFH
Reviewed by CopyMark Law Group
Reg. 5740180Status 710
- Filing date
- Status date
- Registration date
- Apr 30, 2019
- Examiner
- KUNG, KAELIE ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with STEIIIFH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert M. Siminski / Geoffrey D. Aurini
ROBERT M. SIMINSKI / GEOFFREY D. AURINI HARNESS, DICKEY & PIERCE, P.L.C.5445 CORPORATE DRIVESUITE 200TROY, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, solutions for medical and clinical use for the treatment of cells; Biological preparations for the treatment of stem cells; Stem cells for medical purposes; Pharmaceutical preparations for the treatment of autoimmune disease; Cord blood for medical purposes; Bouillons for stem cell cultures; Pharmaceutical preparations for the treatment of stem cell mobilization; Pharmaceutical preparations for immunity adjustment; Allergy medications; Lotions for pharmaceutical purposes, namely, pharmaceutical skin lotions; Medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; Chemico- pharmaceutical preparations for medical purposes, namely, pharmaceutical stem cell formulations for treatment of medical conditions; Chemico-pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations for use in the treatment of bone marrow and stem cell transplantation; Pharmaceutical agents for epidermis; Preparations of microorganisms for medical or veterinary use; Bacterial preparations for medical and veterinary use; Reagents for medical use; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of diseases and disorders in the nature of stem cells for medical use; Dermatological pharmaceutical products; Pharmaceutical preparations for treating skin disorders | SECTION 8 - CANCELLED | Jan 4, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 30, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 30, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 26, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 25, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 24, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 24, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 6, 2019 | IUAF | USE AMENDMENT FILED | — |
| Mar 6, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 7, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 5, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 5, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 5, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 23, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 21, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 21, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 21, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 5, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 18, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 18, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 26, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2017 | ALIE | ASSIGNED TO LIE | — |
| Apr 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2016 | NWAP | NEW APPLICATION ENTERED | — |